McDonald Partners’s TG Therapeutics TGTX Stock Holding History

McDonald Partners’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.4K	Buy	+480	New	+$19.6K	0.01%	376

Other funds holding TGTX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

McDonald Partners's TGTX Position: Q2 2026 in Review

McDonald Partners opened a new position in TG Therapeutics (TGTX) in Q2 2026: 480 shares worth $26.4K. The stake represents 0.01% of the portfolio and ranks #376 among its holdings.

103 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

McDonald Partners held 480 shares of TG Therapeutics worth $26.4K as of Q2 2026.
TG Therapeutics was a new McDonald Partners position in Q2 2026.
TG Therapeutics made up 0.01% of McDonald Partners's portfolio in Q2 2026, its #376 holding.
103 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.